ES2188963T3 - Uso de genisteina como prevencion frente a la fotolesion y el cancer de piel inducidos por radiacion ultravioleta. - Google Patents

Uso de genisteina como prevencion frente a la fotolesion y el cancer de piel inducidos por radiacion ultravioleta.

Info

Publication number
ES2188963T3
ES2188963T3 ES97934083T ES97934083T ES2188963T3 ES 2188963 T3 ES2188963 T3 ES 2188963T3 ES 97934083 T ES97934083 T ES 97934083T ES 97934083 T ES97934083 T ES 97934083T ES 2188963 T3 ES2188963 T3 ES 2188963T3
Authority
ES
Spain
Prior art keywords
skin
photolesion
genisteine
genistein
ultraviolet radiation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934083T
Other languages
English (en)
Inventor
Huachen Wei
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24639167&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2188963(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Application granted granted Critical
Publication of ES2188963T3 publication Critical patent/ES2188963T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Abstract

UN PROCEDIMIENTO PARA INHIBIR LOS EFECTOS PERJUDICIALES DE LOS RAYOS UV PARA LA PIEL HUMANA COMPRENDE LA APLICACION TOPICA DE UNA CANTIDAD TERAPEUTICAMENTE EFECTIVA DE GENISTEINA A LA PIEL, DURANTE UN TIEMPO SUFICIENTEMENTE SIMILAR AL TIEMPO DE EXPOSICION A LOS RAYOS UV, A FIN DE INHIBIR LOS DAÑOS CUTANEOS INDUCIDOS POR TALES RAYOS. SE COMPRUEBA QUE LA GENISTEINA ACTUA COMO AGENTE QUIMIOPREVENTIVO, YA QUE NO TIENE NINGUN EFECTO APRECIABLE DE BLOQUEO DE LA LUZ DEL SOL. LA GENISTEINA PUEDE MEZCLARSE CON UNA SERIE DE EXCIPIENTES Y COMPOSICIONES PARA EL TRATAMIENTO DE LA PIEL.
ES97934083T 1996-06-07 1997-06-09 Uso de genisteina como prevencion frente a la fotolesion y el cancer de piel inducidos por radiacion ultravioleta. Expired - Lifetime ES2188963T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/657,915 US5824702A (en) 1996-06-07 1996-06-07 Genistein as a preventive against ultraviolet induced skin photodamage and cancer

Publications (1)

Publication Number Publication Date
ES2188963T3 true ES2188963T3 (es) 2003-07-01

Family

ID=24639167

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934083T Expired - Lifetime ES2188963T3 (es) 1996-06-07 1997-06-09 Uso de genisteina como prevencion frente a la fotolesion y el cancer de piel inducidos por radiacion ultravioleta.

Country Status (11)

Country Link
US (1) US5824702A (es)
EP (1) EP0918504B1 (es)
JP (1) JP2000511907A (es)
AT (1) ATE234599T1 (es)
AU (1) AU716131B2 (es)
CA (1) CA2257579C (es)
DE (1) DE69719994T2 (es)
DK (1) DK0918504T3 (es)
ES (1) ES2188963T3 (es)
PT (1) PT918504E (es)
WO (1) WO1997046208A2 (es)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN166195A0 (en) 1995-03-13 1995-04-06 Norvet Research Pty Limited Process for glucan extraction
TWI234467B (en) * 1997-06-04 2005-06-21 Univ Michigan Composition for inhibiting photoaging of skin
US20050058709A1 (en) * 1997-06-04 2005-03-17 Fisher Gary J. Methods for inhibiting photoaging of human skin using orally-administered agent
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
AUPP112497A0 (en) 1997-12-24 1998-01-22 Novogen Research Pty Ltd Compositions and method for protecting skin from UV induced immunosupression and skin damage
JP2002506806A (ja) * 1998-03-16 2002-03-05 ザ、プロクター、エンド、ギャンブル、カンパニー 皮膚の外観を調節する組成物
TWI234455B (en) * 1998-04-02 2005-06-21 Univ Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US6683069B1 (en) 1998-04-02 2004-01-27 Regents Of The University Of Michigan Methods and compositions for reducing UV-induced inhibition of collagen synthesis in human skin
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
FR2781154B1 (fr) * 1998-07-15 2001-09-07 Lafon Labor Composition therapeutique a base d'isoflavonoides destinee a etre utilisee dans le traitement des tumeurs par des agents cytotoxiques
US20040131579A1 (en) * 1998-09-10 2004-07-08 Avon Products, Inc. Method and compositions for reducing dermatological aging and for reducing bruising
KR100577914B1 (ko) * 1998-10-09 2006-05-10 가부시키가이샤 야쿠루트 혼샤 피부 외용제
AU2182800A (en) 1998-12-22 2000-07-12 Alcon Laboratories, Inc. Use of inhibitors of gag synthesis for the treatment of corneal haze
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
JP2001131052A (ja) * 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk 化粧品
JP2001131081A (ja) 1999-11-09 2001-05-15 Shinei Ferumentekku:Kk スーパーオキサイド消去剤および飲料
WO2001095901A1 (en) * 2000-06-14 2001-12-20 Alla Shapiro Radioprotective agents
JP4995396B2 (ja) * 2000-06-14 2012-08-08 アメリカ合衆国 植物性エストロゲンのイソフラボン組成物、それらの製剤及び放射線傷害に対する防護および処置用のその使用
US20020012641A1 (en) * 2000-06-26 2002-01-31 Voorhees John J. Use of EGF-R protein tyrosine kinase inhibitors for preventing photoaging in human skin
AU7131001A (en) * 2000-08-08 2001-12-24 Us Health Phytoestrogenic isoflavone compositions, their preparation and use thereof for protection against and treatment of radiation injury
FR2815861B1 (fr) * 2000-10-26 2003-02-28 Oreal Utilisation de l'association d'au moins un carotenoide et d'au moins un isoflavonoide pour traiter les signes cutanes du vieillissement
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
FR2820974B1 (fr) * 2001-02-21 2004-02-13 Pharmascience Lab Composition topique comprenant une solution vraie contenant un derive de chromane ou de chromene, son procede de preparation et son utilisation cosmetique et therapeutique
EP1234572B1 (de) 2001-02-26 2013-10-30 Mibelle AG Cosmetics Isoflavon-Aglykone enhaltende Hautbehandlungsmittel
AU2002255627B2 (en) * 2001-02-27 2008-01-17 The Regents Of The University Of Michigan Use of natural EGFR inhibitors to prevent side effects due to retinoid therapy, soaps, and other stimuli that activate the epidermal growth receptor
US20020160061A1 (en) * 2001-02-28 2002-10-31 Claude Saliou Use of legume products for the treatment of external aggressions
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US6555143B2 (en) 2001-02-28 2003-04-29 Johnson & Johnson Consumer Products, Inc. Legume products
JP4901024B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 ８−ＯＨｄＧ（８−ハイドロキシデオキシグアノシン）産生抑制剤
JP4901025B2 (ja) * 2001-06-22 2012-03-21 株式会社ナリス化粧品 エラスターゼ阻害剤
EP1321123A1 (de) * 2001-12-20 2003-06-25 Cognis France S.A. Verwendung eines Extraktes der Pflanze Baptisia tinctoria in einer kosmetischen Zusammensetzung
KR20050059000A (ko) * 2002-06-25 2005-06-17 코즈메스틱 솔루션즈 프로퍼티 리미티드 국소 화장품용 조성물
AU2002328824A1 (en) * 2002-06-29 2004-01-19 Aquanova German Solubilisate Technologies (Agt) Gmbh Isoflavone concentrate and method for production thereof
DE20213787U1 (de) * 2002-09-04 2002-12-19 Warner Lambert Co Hautpflegemittel
DE10301631A1 (de) * 2003-01-17 2004-07-29 Beiersdorf Ag Kosmetische und dermatologische Zubereitungen mit einem Gehalt an Sojabohnenkeimextrakten in Kombination mit Vitamin C und/oder E sowie alpha-Glycosylrutin
US7718813B2 (en) 2003-08-15 2010-05-18 Nature Pure Labs Sw, Inc. Hydrolysis and purification of active plant compounds suitable for topical application
ES2369928T3 (es) * 2005-06-29 2011-12-09 Dsm Ip Assets B.V. Nanopartículas de isoflavonas y su utilización.
JP5129130B2 (ja) * 2005-06-29 2013-01-23 ディーエスエム アイピー アセッツ ビー．ブイ． イソフラボンのナノ粒子を含む局所組成物
US9345649B2 (en) 2006-12-21 2016-05-24 Avon Products, Inc. Cosmetic composition containing novel fractal particle-based gels
FR2915384B1 (fr) * 2007-04-27 2010-01-15 Vincience Utilisation d'un principe actif issu du soja (glycine maxl.) pour preparer une composition destinee a activer l'energie cellulaire et a proteger la peau des dommages oxydatifs.
FR2915381B1 (fr) * 2007-04-27 2012-06-08 Vincience Utilisation d'un principe actif issu du soja (glycine max l) pour preparer une composition destinee a activer le cytochrome c
FR2915378B1 (fr) * 2007-04-27 2009-08-21 Vincience Sa Utilisation d'un principe actif issu du soja (glycine max l.) pour preparer une composition destinee a proteger les mitochondries
TWI411448B (zh) * 2007-12-27 2013-10-11 Avon Prod Inc 適合用於化妝品之光學模糊色素組合物
CN102596171A (zh) * 2009-12-04 2012-07-18 雅芳产品公司 含有攀援鱼藤的局部组合物以及治疗皮肤的方法
IT1401364B1 (it) * 2010-07-09 2013-07-18 Rottapharm Spa Composizioni dermocosmetiche per protezione solare
US9623003B1 (en) 2013-04-04 2017-04-18 Humanetics Corporation Method of mitigating long and short term detrimental effects of exposure to medical imaging ionizing radiation by administration of genistein

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6061513A (ja) * 1983-09-14 1985-04-09 Sansho Seiyaku Kk 化粧料
JPS62201882A (ja) * 1985-11-18 1987-09-05 Yamanouchi Pharmaceut Co Ltd イソフラボン誘導体
JPH0784383B2 (ja) * 1991-07-23 1995-09-13 辻本化学工業株式会社 抗発癌プロモーター剤
US5545398A (en) * 1993-01-13 1996-08-13 Perricone; Nicholos V. Method and compositions for topical application to the skin of tocotrienol for prevention and/or treatment of skin damage
JP2605607B2 (ja) * 1993-12-08 1997-04-30 日本電気株式会社 半導体集積回路の故障解析装置
US5506211A (en) * 1994-05-09 1996-04-09 The Uab Research Foundation Genistein for use in inhibiting osteroclasts
DE4432947C2 (de) * 1994-09-16 1998-04-09 New Standard Gmbh Mittel zur Behandlung der Haut und seine Verwendung

Also Published As

Publication number Publication date
WO1997046208A3 (en) 1998-02-19
EP0918504B1 (en) 2003-03-19
US5824702A (en) 1998-10-20
PT918504E (pt) 2003-08-29
CA2257579C (en) 2007-08-21
DK0918504T3 (da) 2003-06-02
AU3722597A (en) 1998-01-05
DE69719994T2 (de) 2003-09-04
WO1997046208A2 (en) 1997-12-11
DE69719994D1 (de) 2003-04-24
EP0918504A2 (en) 1999-06-02
AU716131B2 (en) 2000-02-17
ATE234599T1 (de) 2003-04-15
JP2000511907A (ja) 2000-09-12
CA2257579A1 (en) 1997-12-11

Similar Documents

Publication Publication Date Title
ES2188963T3 (es) Uso de genisteina como prevencion frente a la fotolesion y el cancer de piel inducidos por radiacion ultravioleta.
CO5070618A1 (es) Uso de complejos para la preparacion de composiciones para el tratamiento de la piel sensible. proceso de preparacion y composiciones hipoalergicas
ATE162706T1 (de) Mittel zum künstlichen sonnenbräunen und zum schutz der haut gegen uv-strahlen
DE50013433D1 (de) Mittel mit uv-strahlung absorbierender und/oder reflektierender wirkung zum schutz vor gesundheitsschädlicher uv-strahlung und stärkung der natürlichen hautbarriere
ES2135674T3 (es) Composiciones cosmeticas antisolares y utilizaciones.
BR0208123A (pt) Composição contendo extrato de matricária e seu uso
BR9106891A (pt) Composiçoes para o tratamento da pele
GR3027749T3 (en) Cosmetic or pharmaceutical composition for topical application active against free radicals.
CO5180597A1 (es) Composiciones anhidras utiles como filtros para rayos ultra violeta con un factor de proteccion solar alto
TR200001131A3 (tr) Bitkiler için bitki koruyucu islem ve bilesim.
MX9602782A (es) Composicion bloqueadora para el uso cosmetico o dermatologico, que contiene un agente formador de quelatos de hierro.
PE20000152A1 (es) Articulo absorbente y metodo de envoltura
MX9304117A (es) Agente cosmetico para el tratamiento de la piel, contra el envejecimiento provocado por los rayos ultravioleta y procedimiento para su obtencion.
DE69835224D1 (de) Photoempfindliche sonnenschutzmittel
MX9602880A (es) Uso de un agente antioxidante y/o antiradicales en una composicion bloqueadora o filtrante para uso cosmetico o dermatologico.
DE60325904D1 (de) Kosmetische und/oder pharmazeutische zubereitung eür die behandlung und die prävention von reizungen, entzündungen und hauterythema
ATE99922T1 (de) Lichtschutzmittel mit verbesserter wirkung.
BR9508896A (pt) COmposição perfumada para o tratamento tópico da pele
ATE375163T1 (de) Zusammensetzungen enthaltend vernix und ein uv- schutzmittel, und deren verwendung
PT90085A (pt) Processo para a preparacao de composicoes farmaceuticas contendo um complexo organico de ouro para aplicacao topica
AU2001275004A1 (en) Use of cox2 inhibitors for treating skin injury from exposure to ultraviolet radiation
AR006489A1 (es) Composicion cosmetica y procedimiento de tratamiento cosmetico para proteger la piel y/o los cabellos contra la radiacion uv, en particular la radiacion solar
HUP0303375A3 (en) Pharmaceutical and cosmetic compositions for the protection of the skin from damages induced by sun radiations
BR9805928A (pt) Composição cosmética ou farmacêutica e processos paraa proteger as células da pele de pano por uv, e para evitar o fotoenvelhicemento.
BR0009860A (pt) Composições cosméticas de uso tópico que contém um derivado de benzotriazol e um bis-resorcinol triazina, uso das mesmas e processo de tratamento cosmético